XML 21 R3.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 27, 2025
Sep. 28, 2024
Current assets:    
Cash and cash equivalents $ 174,668 $ 169,732
Marketable securities 52,858 51,426
Accounts receivable, net of allowances of $66,098 and $51,741 as of September 27, 2025, and September 28, 2024, respectively 65,847 44,513
Inventories 171,020 231,505
Prepaid and other current assets 39,642 53,910
Total current assets 504,035 551,086
Property and equipment, net 72,277 102,148
Operating lease right-of-use assets 45,297 50,175
Goodwill 82,854 82,854
Intangible assets, net:    
In-process research and development 0 73,770
Other intangible assets 75,356 14,266
Deferred tax assets 10,509 10,314
Other noncurrent assets 32,950 31,699
Total assets 823,278 916,312
Current liabilities:    
Accounts payable 184,109 194,590
Accrued expenses 79,094 87,783
Accrued compensation 21,331 15,701
Deferred revenue, current 21,771 21,802
Other current liabilities 46,107 46,277
Total current liabilities 352,412 366,153
Operating lease liabilities, noncurrent 53,288 56,588
Deferred revenue, noncurrent 59,453 61,075
Deferred tax liabilities 126 60
Other noncurrent liabilities 2,774 3,816
Total liabilities 468,053 487,692
Commitments and contingencies (Note 12)
Stockholders’ equity:    
Common stock, $0.001 par value; 500,000,000 shares authorized, 122,881,915 and 123,046,510 shares issued, 120,093,113 and 121,763,776 shares outstanding as of September 27, 2025, and September 28, 2024, respectively 123 123
Treasury stock, 2,788,802 and 1,282,734 shares at cost as of September 27, 2025 and September 28, 2024, respectively (37,398) (17,096)
Additional paid-in capital 502,775 498,245
Accumulated deficit (112,078) (50,934)
Accumulated other comprehensive income (loss) 1,803 (1,718)
Total stockholders' equity 355,225 428,620
Total liabilities and stockholders’ equity $ 823,278 $ 916,312